Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.36B |
| 2 |
Tesla
TSLA
|
+$1.09B |
| 3 |
Amazon
AMZN
|
+$1B |
| 4 |
Microsoft
MSFT
|
+$963M |
| 5 |
Apple
AAPL
|
+$864M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.22B |
| 2 |
Bank of America
BAC
|
+$1.2B |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$381M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$294M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.44% |
| 2 | Technology | 25.75% |
| 3 | Financials | 6.27% |
| 4 | Consumer Discretionary | 5.79% |
| 5 | Industrials | 5.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5151
ALPS Equal Sector Weight ETF
EQL
$787M
| $5.95K | ﹤0.01% |
+118
| New | +$5.89K |
2026 Q2
0 quarters
|
|
5152
Frontier Nuclear and Minerals Inc
FNUC
$25.2M
| $5.91K | ﹤0.01% |
+3,861
| New | +$8.44K |
2026 Q2
0 quarters
|
|
5153
International General Insurance
IGIC
$1.06B
| $5.86K | ﹤0.01% |
224
-42
| -16% | -$1.07K |
2026 Q1
1 quarter
|
|
5154
Global Partners
GLP
$1.61B
| $5.82K | ﹤0.01% |
+125
| New | +$5.9K |
2026 Q2
0 quarters
|
|
5155
WisdomTree Yield Enhanced US Aggregate Bond Fund
AGGY
$893M
| $5.56K | ﹤0.01% |
128
-3,725
| -97% | -$162K |
2022 Q2
16 quarters
|
|
5156
AEON Biopharma
AEON
$16.1M
| $5.26K | ﹤0.01% |
7,315
+6,573
| +886% | +$5.5K |
2026 Q1
1 quarter
|
|
5157
NovaBridge Biosciences American Depositary Shares
NBP
$124M
| $5.25K | ﹤0.01% |
2,690
-497
| -16% | -$1.01K |
2020 Q4
22 quarters
|
|
5158
WeShop Holdings
WSHP
$27.2M
| $5.24K | ﹤0.01% |
+672
| New | +$4.89K |
2026 Q2
0 quarters
|
|
5159
Invesco CEF Income Composite ETF
PCEF
$742M
| $5.2K | ﹤0.01% |
256
| – | – |
2024 Q1
9 quarters
|
|
5160
Jyong Biotech
MENS
$140M
| $5.18K | ﹤0.01% |
2,501
-286
| -10% | -$607 |
2025 Q4
2 quarters
|
|
5161
LanzaTech
LNZA
$64.5M
| $5.13K | ﹤0.01% |
752
+542
| +258% | +$8.57K |
2023 Q1
13 quarters
|
|
5162
DELISTED
Aptorum Group
APM
| $5K | ﹤0.01% |
+6,398
| New | +$5.67K |
2026 Q2
0 quarters
|
|
5163
Bicycle Therapeutics
BCYC
$257M
| $4.98K | ﹤0.01% |
1,175
-120
| -9% | -$550 |
2021 Q1
21 quarters
|
|
|
DRK
5164
DarkHorse Technologies Inc. Common Shares
DRK
$18.6M
| $4.97K | ﹤0.01% |
+1,800
| New | +$4.07K |
2026 Q2
0 quarters
|
|
5165
Humacyte
HUMA
$111M
| $4.82K | ﹤0.01% |
6,178
-4,871
| -44% | -$4.51K |
2021 Q3
19 quarters
|
|
5166
iShares MSCI France ETF
EWQ
$350M
| $4.82K | ﹤0.01% |
106
-7
| -6% | -$318 |
2022 Q1
17 quarters
|
|
5167
CALL
Blue Gold Ltd Warrant
BGLWW
$167K
| $4.8K | ﹤0.01% |
50,001
| – | – |
2025 Q3
3 quarters
|
|
5168
JPMorgan International Research Enhanced Equity ETF
JIRE
$11B
| $4.78K | ﹤0.01% |
58
+11
| +23% | +$883 |
2026 Q1
1 quarter
|
|
5169
Global X Morningstar Capital Allocation Leaders ETF
CPTL
$112M
| $4.7K | ﹤0.01% |
100
| – | – |
2019 Q4
26 quarters
|
|
5170
Fidelity International Value Factor ETF
FIVA
$633M
| $4.62K | ﹤0.01% |
+120
| New | +$4.49K |
2026 Q2
0 quarters
|
|
5171
CALL
Scage Future Warrants
SCAGW
$130K
| $4.61K | ﹤0.01% |
112,501
| – | – |
2025 Q3
3 quarters
|
|
5172
SOAR AI, Inc.
SOAR
$12.5M
| $4.59K | ﹤0.01% |
28,319
+26,166
| +1,215% | +$5.58K |
2026 Q1
1 quarter
|
|
5173
Docebo
DCBO
$737M
| $4.44K | ﹤0.01% |
248
-30
| -11% | -$533 |
2026 Q1
1 quarter
|
|
5174
Yiren Digital
YRD
$36.2M
| $4.43K | ﹤0.01% |
5,300
| – | – |
2025 Q2
4 quarters
|
|
5175
CALL
Tevogen Inc Warrant
TVGNW
$1.41M
| $4.39K | ﹤0.01% |
77,151
| – | – |
2025 Q2
4 quarters
|
|
Similar funds
Citigroup's Q2 2026 Portfolio in Review
As of Q2 2026, Citigroup held 6,442 positions worth $303B, up 29% from $235B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup deployed $27.6B of net new capital in Q2 2026, opening 555 new positions and adding to 3,283 existing holdings. Its largest new stake was Honeywell Aerospace: 579,875 shares worth $128M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 45% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.22B trimmed.
- Citigroup's largest Q2 2026 buy was Honeywell Aerospace: 579,875 shares worth $128M.
- Citigroup added most to NVIDIA in Q2 2026, an estimated $2.36B increase.
- Citigroup's biggest Q2 2026 reduction was iShares Russell 2000 ETF, cutting an estimated $1.22B.
- Citigroup fully exited Sealed Air in Q2 2026, selling an estimated $111M.
- Citigroup's ten largest holdings make up 20% of its $303B portfolio in Q2 2026.
- Citigroup opened 555 new positions and closed 760 in Q2 2026.
- Citigroup's portfolio value rose 29% quarter-over-quarter to $303B.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.